Class information for:
Level 1: MESOTHELIN//ERC MESOTHELIN//MORAB 009

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
28347 209 32.8 90%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
531 3       MESOTHELIOMA//ASBESTOS//MALIGNANT MESOTHELIOMA 19648
1763 2             MESOTHELIOMA//MALIGNANT PLEURAL MESOTHELIOMA//MALIGNANT MESOTHELIOMA 6423
28347 1                   MESOTHELIN//ERC MESOTHELIN//MORAB 009 209

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 MESOTHELIN authKW 5295922 39% 45% 81
2 ERC MESOTHELIN authKW 730512 2% 100% 5
3 MORAB 009 authKW 608758 2% 83% 5
4 SS1P authKW 521792 2% 71% 5
5 LUMINAL MEMBRANE EXPRESSION authKW 438307 1% 100% 3
6 AMATUXIMAB authKW 328729 1% 75% 3
7 ANTIBODY THER Y UNIT address 292205 1% 100% 2
8 CELL SURVIVAL PROLIFERATION authKW 292205 1% 100% 2
9 HUMAN MESOTHELIN authKW 194802 1% 67% 2
10 N ERC MESOTHELIN authKW 194802 1% 67% 2

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Oncology 2993 61% 0% 128
2 Pathology 190 9% 0% 19
3 Medicine, Research & Experimental 86 9% 0% 18
4 Medical Laboratory Technology 73 3% 0% 7
5 Anatomy & Morphology 33 2% 0% 4
6 Biochemistry & Molecular Biology 11 11% 0% 23
7 Respiratory System 10 2% 0% 5
8 Genetics & Heredity 10 4% 0% 9
9 Immunology 7 5% 0% 10
10 Pharmacology & Pharmacy 7 6% 0% 13

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 ANTIBODY THER Y UNIT 292205 1% 100% 2
2 FORENS MED OCCUPAT MED MED PSYCHOL CRIMINO 146102 0% 100% 1
3 INTERDISCIPLINARY MED PALLIAT CARE NURSING 146102 0% 100% 1
4 INTERNAL MED 1SECT MOL GI ONCOL 146102 0% 100% 1
5 MOL DIAGNOST PROGARM 146102 0% 100% 1
6 PALLIAT CARE INTERDISCIPLINARY 146102 0% 100% 1
7 SOLID TUMOR IMMUNOTHER Y SECT 146102 0% 100% 1
8 SWEDISH HOSP TUMOR 146102 0% 100% 1
9 UMR MATRICE EXTRACELLULAIRE DYNAM CELLULAIRE 73 146102 0% 100% 1
10 VIVIAN L SMITH NEUROSUR 146102 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 MOLECULAR CANCER THERAPEUTICS 3583 5% 0% 10
2 CLINICAL CANCER RESEARCH 3548 9% 0% 19
3 CANCER SCIENCE 3351 4% 0% 9
4 JOURNAL OF CANCER 1752 1% 0% 3
5 APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY 1568 2% 0% 4
6 GENE THERAPY 591 2% 0% 4
7 JOURNAL OF BIOMEDICAL NANOTECHNOLOGY 391 1% 0% 2
8 IDRUGS 390 0% 0% 1
9 INTERNATIONAL JOURNAL OF CANCER 345 3% 0% 7
10 JOURNAL OF IMMUNOTHERAPY 344 1% 0% 2

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 MESOTHELIN 5295922 39% 45% 81 Search MESOTHELIN Search MESOTHELIN
2 ERC MESOTHELIN 730512 2% 100% 5 Search ERC+MESOTHELIN Search ERC+MESOTHELIN
3 MORAB 009 608758 2% 83% 5 Search MORAB+009 Search MORAB+009
4 SS1P 521792 2% 71% 5 Search SS1P Search SS1P
5 LUMINAL MEMBRANE EXPRESSION 438307 1% 100% 3 Search LUMINAL+MEMBRANE+EXPRESSION Search LUMINAL+MEMBRANE+EXPRESSION
6 AMATUXIMAB 328729 1% 75% 3 Search AMATUXIMAB Search AMATUXIMAB
7 CELL SURVIVAL PROLIFERATION 292205 1% 100% 2 Search CELL+SURVIVAL+PROLIFERATION Search CELL+SURVIVAL+PROLIFERATION
8 HUMAN MESOTHELIN 194802 1% 67% 2 Search HUMAN+MESOTHELIN Search HUMAN+MESOTHELIN
9 N ERC MESOTHELIN 194802 1% 67% 2 Search N+ERC+MESOTHELIN Search N+ERC+MESOTHELIN
10 ADOPTIVE SERUM TRANSFER 146102 0% 100% 1 Search ADOPTIVE+SERUM+TRANSFER Search ADOPTIVE+SERUM+TRANSFER

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 HASSAN, R , THOMAS, A , ALEWINE, C , LE, DT , JAFFEE, EM , PASTAN, I , (2016) MESOTHELIN IMMUNOTHERAPY FOR CANCER: READY FOR PRIME TIME?.JOURNAL OF CLINICAL ONCOLOGY. VOL. 34. ISSUE 34. P. 4171 -+ 57 70% 0
2 TANG, ZW , QIAN, M , HO, M , (2013) THE ROLE OF MESOTHELIN IN TUMOR PROGRESSION AND TARGETED THERAPY.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 13. ISSUE 2. P. 276-280 32 84% 29
3 BAYOGLU, IV , KUCUKZEYBEK, BB , KUCUKZEYBEK, Y , VAROL, U , YILDIZ, I , ALACACIOGLU, A , AKYOL, M , DEMIR, L , DIRICAN, A , YILDIZ, Y , ET AL (2015) PROGNOSTIC VALUE OF MESOTHELIN EXPRESSION IN PATIENTS WITH TRIPLE NEGATIVE AND HER2-POSITIVE BREAST CANCERS.BIOMEDICINE & PHARMACOTHERAPY. VOL. 70. ISSUE . P. 190 -195 28 82% 0
4 PASTAN, I , HASSAN, R , (2014) DISCOVERY OF MESOTHELIN AND EXPLOITING IT AS A TARGET FOR IMMUNOTHERAPY.CANCER RESEARCH. VOL. 74. ISSUE 11. P. 2907-2912 26 65% 31
5 EINAMA, T , HOMMA, S , KAMACHI, H , KAWAMATA, F , TAKAHASHI, K , TAKAHASHI, N , TANIGUCHI, M , KAMIYAMA, T , FURUKAWA, H , MATSUNO, Y , ET AL (2012) LUMINAL MEMBRANE EXPRESSION OF MESOTHELIN IS A PROMINENT POOR PROGNOSTIC FACTOR FOR GASTRIC CANCER.BRITISH JOURNAL OF CANCER. VOL. 107. ISSUE 1. P. 137-142 21 95% 18
6 KOBAYASHI, K , SASAKI, T , TAKENAKA, F , YAKUSHIJI, H , FUJII, Y , KISHI, Y , KITA, S , SHEN, LH , KUMON, H , MATSUURA, E , (2015) A NOVEL PET IMAGING USING CU-64-LABELED MONOCLONAL ANTIBODY AGAINST MESOTHELIN COMMONLY EXPRESSED ON CANCER CELLS.JOURNAL OF IMMUNOLOGY RESEARCH. VOL. . ISSUE . P. - 30 67% 0
7 HASSAN, R , HO, M , (2008) MESOTHELIN TARGETED CANCER IMMUNOTHERAPY.EUROPEAN JOURNAL OF CANCER. VOL. 44. ISSUE 1. P. 46-53 25 63% 122
8 ZHANG, JL , BERA, TK , LIU, WH , DU, X , ALEWINE, C , HASSAN, R , PASTAN, I , (2014) MEGAKARYOCYTIC POTENTIATING FACTOR AND MATURE MESOTHELIN STIMULATE THE GROWTH OF A LUNG CANCER CELL LINE IN THE PERITONEAL CAVITY OF MICE.PLOS ONE. VOL. 9. ISSUE 8. P. - 17 100% 0
9 KAWAMATA, F , KAMACHI, H , EINAMA, T , HOMMA, S , TAHARA, M , MIYAZAKI, M , TANAKA, S , KAMIYAMA, T , NISHIHARA, H , TAKETOMI, A , ET AL (2012) INTRACELLULAR LOCALIZATION OF MESOTHELIN PREDICTS PATIENT PROGNOSIS OF EXTRAHEPATIC BILE DUCT CANCER.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 41. ISSUE 6. P. 2109 -2118 24 71% 8
10 KELLY, RJ , SHARON, E , PASTAN, I , HASSAN, R , (2012) MESOTHELIN-TARGETED AGENTS IN CLINICAL TRIALS AND IN PRECLINICAL DEVELOPMENT.MOLECULAR CANCER THERAPEUTICS. VOL. 11. ISSUE 3. P. 517-525 26 58% 33

Classes with closest relation at Level 1



Rank Class id link
1 948 MESOTHELIOMA//MALIGNANT PLEURAL MESOTHELIOMA//MALIGNANT MESOTHELIOMA
2 7843 DIPHTHERIA TOXIN//PSEUDOMONAS EXOTOXIN//IMMUNOTOXIN
3 2789 CA 125//HE4//CA125
4 6782 MESOTHELIOMA//MALIGNANT MESOTHELIOMA//WELL DIFFERENTIATED PAPILLARY MESOTHELIOMA
5 12017 PANCREATIC CANCER//PANCREATIC JUICE//K RAS
6 13646 AFFIBODY MOLECULE//AFFIBODY//BIOMED RADIAT SCI
7 23614 FASCIN//FASCIN 1//FSCN1
8 2862 CHIMERIC ANTIGEN RECEPTOR//ADOPTIVE CELL THERAPY//SURG BRANCH
9 34386 MOL BIOL VIRAL ONCOGENESIS//HYPERVARIABLE EPITOPE CONSTRUCTS//LENTIVIRAL VLP
10 6138 PANCREATIC CANCER//GEMCITABINE//ADVANCED PANCREATIC CANCER

Go to start page